A study of invasive cervical cancer in Southampton and South West Hampshire is reported, covering three consecutive three year periods during which the screening coverage increased from an estimated 60% to a recorded 87% of eligible women aged 20-64. From the first to the third periods of the study in that age group registrations of fully invasive squamous cell carcinoma (stage Ib and above) fell from 64 to 30 (53%), which was largely counteracted by an increase in microinvasive squamous cell carcinoma (linear trend: P<O·OOOI). In the same age group registrations of adenocarcinoma rose slightly, which resulted from an increase in the number diagnosed at a depth of invasion of less than 3 1YlIYl. There were no significant changes in the numbers of stage III and IV cancers or among cancers in women aged 65 and over. A strong inverse association was found between stage of both histological types of cancer and their likelihood of being screen detected rather than symptomatict 91% of screen detected cancers were diagnosed at stage I compared with 38% of symptomatic cancers.
Abstract
A study of invasive cervical cancer in Southampton and South West Hampshire is reported, covering three consecutive three year periods during which the screening coverage increased from an estimated 60% to a recorded 87% of eligible women aged 20-64. From the first to the third periods of the study in that age group registrations of fully invasive squamous cell carcinoma (stage Ib and above) fell from 64 to 30 (53%), which was largely counteracted by an increase in microinvasive squamous cell carcinoma (linear trend: P<O·OOOI). In the same age group registrations of adenocarcinoma rose slightly, which resulted from an increase in the number diagnosed at a depth of invasion of less than 3 1YlIYl. There were no significant changes in the numbers of stage III and IV cancers or among cancers in women aged 65 and over. A strong inverse association was found between stage of both histological types of cancer and their likelihood of being screen detected rather than symptomatict 91% of screen detected cancers were diagnosed at stage I compared with 38% of symptomatic cancers.
There was a slight downward trend in the incidence of cancer per 100 000 total female population across the three periods of the study with a significant trend towards low stage disease, which is likely to reduce mortality in years to COIne. The trend towards screen detected cancers and cancers ofless than 31Yl1Yl depth ofinvasion is presented as a positive outcome to be expected in early rounds of increasing the screening coverage.
In 1988 the National Health Service cervical screening programme was introduced throughout England and Wales. Since then all women aged 20-64 have been invited for screening, with a recall interval varying between three and five years. For the few years leading up to that date increasing numbers of general practitioners and district health authorities had been introducing their own screening programmes. In many districts, including Southampton and South West Hampshire, data on population coverage were incomplete until 1990 when general practitioner contracts were introduced based on target percentages of women screened within the preceding five years. Since 1991 the average screening coverage of women aged 20-64, excluding those who have had hysterectomies, has been over 80%.1 Before the introduction of the national programme the incidence of invasive cervical cancer in the United Kingdom was one of the highest among countries ofthe European Community, second only to Denmark." The majority of women developing cancer had not been screened and were diagnosed as a result of the investigation of symptoms. J There are few results available from individual screening centres after the introduction of the NHS cervical screening programme, but nationally the incidence has not fallen and the recent trend has been upwards," 4 consistent with the detection of undiagnosed invasive disease in previously unscreened or poorly screened women. An increased incidence has been reported in early rounds of successful screening programmes elsewhere" and was predicted for the prevalence round of the NHS breast screening programme." Despite the recent increase in incidence, mortality from cervical screening has fallen since 1991, reversing the previous upward trend in women aged 45 and under;"
The national programme has been introduced in a partially screened population making its effect difficult to assess, particularly at a time when the prevalence of the disease may be affected by an increased risk of cervical cancer and its precursors. Trends in registration have suggested an increased risk in the cohort of women born since 1941, the oldest of whom are now entering their sixth decade." An increase in registrations of adenocarcinoma has been recorded in young women, which may reflect an underlying increased risk for all cervical cancers, considering that adenocarcinoma is less likely than squamous cell carcinoma to be detected by screening and treated at a preinvasive stage. 9 10 In this study we describe registrations of invasive cancer in three consecutive periods of three years before, during, and after the full implementation of the NHS cervical screening programme in four age groups of women in whom the changes of screening coverage were known to have been different. Stage at diagnosis and mode of presentation (whether symp-tornatic or screen detected) have been analysed in an attempt to assess the effect of increasing the screening coverage. F our age groups were analysed, defined by the age at the time of cancer diagnosis (see tables 1a and 1b). From local unpublished data collected in 1984, the screening coverage before the start of the study was estimated to be greater in the youngest than in the oldest of the three age groups of women aged 20-64. Most of the women born since 1941, the cohort believed to be at greater risk for cervical cancer.i were included in the first two age groups. Women aged 65 and older were not invited for screening.
Population, subjects, and methods

DATA COLLECTION
Cervical cancers diagnosed between 1985 and 1993 were retrieved from computerised histology records at Southampton General Hospital and requested from local private hospitals and NHS hospitals in bordering districts. Registrations of invasive carcinoma of the cervix were obtained from the cancer registry held by the Wessex cancer intelligence unit and from records kept by the Wessex radiotherapy and oncology units. Information on deaths was obtained from the Wessex cancer intelligence unit and the Office of Population Censuses and Surveys. All records were validated and duplicate records and miscoded cases (mostly CINIII and endometrial cancer) were excluded from the study.
TYPE AND STAGE OF CANCER
In most instances the histological type of the original report was used and additional mucin staining was not carried out as part of the study. Histological type was recorded for 304 of 310 cancers (tables la and Ib). One basaloid/reserve cell carcinoma was included with the squamous cell carcinomas and one adenoid cystic carcinoma with coexisting CINIII with the adenocarcinomas. Six carcinomas of unknown type have been considered with the squamous cell carcinomas and 12 adeno-squamous carcinomas with the adenocarcinomas.
Histology was reviewed to verify the diagnosis in the majority of cases, including 12 in which there was ambiguity in the report about the uterine site of the tumour: seven were confirmed as cervical and five as endometrial. Because different criteria had been used to classify microinvasive carcinomas, these were reviewed and the depth and extent of invasion measured. Microinvasive squamous cell carcinoma (stage Ia) was defined as those with a depth of invasion less than 3 mm and lateral extent less than 7 mm, using the classification of the Society of Gynecological Oncologists" and Japan Society of Gynecologists" rather than that of the International Federation of Gynecology and Obstetrics (FIGO). 14 Six cases originally reported as microinvasive cancer were revised to CINIII infiltrating endocervical crypts and excluded from the study and eight cases were revised to stage lb.
There is no accepted definition of "microinvasive adenocarcinoma". 15 In this study those of less than 3 mm depth of invasion, including early stromal invasion, were classified as stage Ia for purposes of clinical management as well as for analysis in the study. FIGO stage Ib and above was assessed by HM, who was collator of results for the annual report of the treatment in gynaecological cancer.
MODE OF PRESENTATION
The cases were divided into those in which cancer was diagnosed as a result of the investigation of symptoms (symptomatic) and those in which cancer was diagnosed in asymptomatic women as a result of the investigation of an abnormal cervical smear (screen detected). The mode of presentation was initially assessed from data on cytology request cards and histology reports. Further information was obtained from general practitioner referral letters and other information from general practitioner records and medical records in gynaecology, radiotherapy, and oncology. If there was any doubt, the general practitioner was contacted by letter for confirmation.
DATA COLLATION AND ANALYSIS
Patient demographic data, histological diagnosis, stage of cancer, mode ofdiagnosis (symptomatic or screen detected), and screening histories were collated using a Paradox version 4.0 database and analysed using SPSS/ PC +version 4.0. The incidence of cancer was analysed as a Poisson variable using GUM version 3.77.
SOUTHAMPTON AND SOUTH WEST HAMPSHIRE SCREENING PROGRAMME
From September 1988 invitations letters were sent to all women aged 20-64 who were not recorded as having been screened within the preceding five years. By the end of 1990 all women in that age group had been invited for Table 1a and 1b Stage of cancer related 10 age at diagnosis and period of study (period A = 1985-1987, period B= 1988-1990, period C= 1991-1993 
a 232 squamous cell carcinomas and six carcinomas, type unknown la, <3 mm (28)  1  0  3  0  4  13  1  1  3  2  5  19  0  1  1  lb, >3 mm (96)  7  7  5  17  10  7  8  13  4  32  30  16  7  8  3  II (54)  5  1  0  8  2  2  9  3  3  22  6  5  9  4  8  III and IV (57)  0  0  0  4  4  5  6  2  2  10  6  7  8  17  9  "Invasive" (3)  0  0  0  0  0  1  0  0  1  0  0  2  0  0  1  Total (238)  13  8  8  29  20  28  24  19  13  66  47  49  24  30 22 Carcinoma, type unknown (6) (1) (1) (I) The exact stage of cancer was determined for 304 of 310 cancers. In three cases it was only known that the cancer was invasive, and was assumed to be at least stage Ib, and in three cases it was known to be at least stage II: the latter three cases have been included with stage II cancers. Subgroups of stage II have been combined, as have stages III and IV and their subgroups. Two invasive vaginal vault cancers were classified as stage II: these had followed previously treated CINIII and were therefore classified as cervical rather than vaginal cancers. Stage of cancer was analysed separately for squamous cell and unclassified carcinomas (n = 238) and adenocarcinomas and adenosquamous carcinomas (n = 72) (tables 1a and 1b).
In the screening age groups there was an increase in microinvasive squamous cell carcinomas from two to 19 which was most pronounced in women aged 35-49 (table 1a) . Fully invasive squamous cell carcinomas (stage Ib and over) fell from 64 to 30 (53%), and there was a slight fall in the total number of squamous cell carcinomas. Over the three periods of the study there was a significant linear trend in numbers of microinvasive com- Table 2 Stage at diagnosis related 10 mode of presentation pared with fully invasive squamous cell cancers of stage Ib and over (X 2 trend: 27'10, 1 df, P<O·OOOl).
Among adenocarcinomas in the screening age group (table 1b) there was an increase from none to eight in the number of cancers diagnosed at a depth of invasion less than 3 mm, again most pronounced among women aged 35-49. There was no fall in cancers with a depth of invasion greater than 3 mm and there was an increase in the total numbers of adenocarcinomas and adenosquamous carcinomas in the screening age groups from the first to the third periods of the study.
When all histological types of cancer are considered together, downward trends are seen in women aged 20-34 and 50-64 -greater in the latter group who had the lowest screening coverage at the start of the study. An increase is seen in the third period among women aged 35-49 years. The number of cancers diagnosed at stage II and above in the screening age group fell from 38 to 16 (58%). There was a significant linear trend for stage I cancers compared with stage II and above (X 2 trend: 10,13, 1 df, P=0·0015).
There was no change in the small numbers of stage III and IV cancers even in the screening age groups. Cancers in women aged 65 and over show a small peak in the middle period of the study for both histological types and all stages of cancer. STAGE The incidence of cancer was analysed using GUM version 3·77 as a Poisson variable with three times the Office of Population Censuses and Surveys (OPCS) population figure for each time period (A, B, and C) included as an offset. X' Statistics for differences between the three time periods and trend over the three periods are presented. Numbers of cancers are given in brackets.
result of the investigation of symptoms. In a minority of cases, which we were unable to quantify, the abnormal cervical smear may have initiated referral.
In 97 women the cancers were diagnosed in asymptomatic women and classified as screen detected, of whom 95 were diagnosed as a direct result of the investigation of an abnormal cervical smear. Two women were difficult to classify, but were included with the screen detected cases because they consistently claimed to be symptom free at the time of diagnosis, and the diagnosis was made as a direct result of an invitation for a cervical smear. One was called for screening but a smear was not taken because of vaginismus: a mass was noticed on examination and cervical cancer subsequently diagnosed. One was found to have a procidentia when called for a routine smear which was negative: hysterectomy revealed microinvasive carcinoma.
In 17 women with screen detected cancers minor gynaecological symptoms were noted, such as comments about "heavy periods" or recollections of some form of discharge on direct questioning after the diagnosis had been made. In 24 some degree of abnormality was noted at the time of taking the smear, ranging from "erosion" or "cervicitis" to a clinical suspicion of cancer. Although these women were asymptomatic when referred, one developed symptoms between referral and biopsy and one after an initial biopsy diagnosis of CIN. In 14 women, 12 of whom were screen detected, the diagnosis of invasive cancer was made within five years of treatment for CIN. Six of97 screen detected cancers were in women aged 65 and over.
There was a strong association between the stage of cancer and its mode of presentation: 91 % (88/97) of screen detected cancers were diagnosed at stage I compared with 38% (80/ 213) of symptomatic cancers (X 2 = 20'43, P<0·0001). The percentages were similar for squamous cell and adenocarcinomas. All the adenocarcinomas diagnosed at a depth of invasion of less than 3 mm were screen detected.
Five year survival was determined for women in the first period of the study only, because no data were available after 1992. Among women aged 20-64 five year survival was 91 % (21 of 23) for screen detected cancers compared with 64% (38 of 59) for symptomatic cancers. Information on cause of death was incomplete, but causes other than cervical cancer were less likely to be relevant in women under the age of 64.
Incidence of invasive cervical cancer, 1985-1993, women of all ages, Southampton and South west Hampshire. The incidence shown is the parameter used by the NHS cervical screeningprogramme for the Health of the Nation target for the year 2000. 27 (table 3) Across the three periods of the study there was a downward trend in the incidence of invasive cancer per 100 000 total female population, which was not statistically significant (table 3) . However, when the incidence was related to stage of cancer at diagnosis there was a significant trend towards low stage disease as shown in the figure.
INCIDENCE OF CANCER
Discussion
During a nine year period, in which the screening coverage of eligible women aged 20-64 increased from an estimated 60% to a recorded 87%, registrations of stage Ib and II squamous cell carcinomas more than halved in the screening age group, counteracted by an increase in carcinomas diagnosed at a depth of invasion less than 3 mm. The changes in stage were '13 c considered to be a direct result of the increased screening coverage because there was a strong association between low stage and likelihood of the cancer being screen detected rather than symptomatic. Also, the changes in stage and mode of presentation were not seen among women aged 65 and over.
Cervical screening aims at preventing invasive cancer by detecting and ablating the disease when preinvasive. Screen detected cancers must therefore be considered within the spectrum of failures of the screening programme. Furthermore, it is not always easy to determine whether or not a cervical cancer was screen detected. Gynaecological symptoms are common and routine cervical smears are often taken within the interval recommended for recall. Increased awareness of cervical cancer in younger women may result in more prompt investigation of symptoms, and abnormal smears may initiate referral in symptomatic women. Nevertheless, the importance of determining mode of presentation is shown by its close correlation with stage. The present study agrees with that of Pretorius et at, in which 90% of screen detected cancers were diagnosed at stage I compared with 38% of symptomatic cancers."
The increase in registrations of cancers at a depth of invasion of less than 3 mm was seen in adenocarcinomas as well as squamous cell carcinomas. Microinvasive squamous cell carcinoma carries a low risk of lymph node metastasis and may therefore be treated by local excision, as for CINIII, especially if the lower limit of 3 mm depth of invasion is used. IS 19 Stage I cancers have a five year survival of 80-90%/0 which is likely to improve as the proponion that are microinvasive increases, as was seen in the third period of the present study.
Although there is no agreed definition of microinvasive adenocarcinoma, and stage for stage, adenocarcinoma carries a worse prognosis than squamous cell carcinoma," all except one of the women with adenocarcinomas ofless than 3 mm depth of invasion were treated by local surgery without radiotherapy. These cancers were all in women aged less than 50 and were screen detected, confirming that screening has an important role in the detection of this type of cancer at an early stage, though it may be more difficult to identify and prevent when preinvasive." The increase in registrations of adenocarcinoma and adenosquamous carcinoma in the present study is similar to that reponed elsewhere,9102324 although those increases were not restricted to cancers with a depth of invasion less than 3 mm. The slight increase in adenosquamous carcinoma, which tends to have a worse prognosis than squamous cell carcinoma," may relate to improved diagnosis through the more frequent use of mucin staining.
The NHS cervical screening programme was superimposed on a partially screened population whose underlying risk of cancer in unscreened women was unknown. Furthermore, it is probable that the risk of cervical cancer was increasing during the 1980s when the cohort of 27 women born since 1941 entered their fifth decade of life: an increase in mortality from women aged less than 35 was the first indication of this phenomenon." This study suggests a relatively high prevalence of early invasive carcinoma in women aged 35-49, though the numbers were too small to be statistically significant.
Reports of comprehensive screening programmes elsewhere have shown that there may be an increase in the incidence of invasive cancer in early rounds of screening, with a trend towards low stage disease when previously undiagnosed lesions are detected among unscreened or poorly screened women. 56 This was predicted for the NHS breast screening programme? but was not widely recognised as a likely consequence of introducing the NHS cervical screening programme. Incidence has also been reponed to be lower after two or more rounds of screening, reflecting the relative low sensitivity of a single cervical smear."
In Southampton and South West Hampshire the overall trend in incidence is downwards and a significant trend towards screen detected and microinvasive disease is presented as a positive outcome at an early stage of a comprehensive screening programme.
